Please assess the completion status of the following clinical trial:

Trial Title: Exploratory Propofol Dose Finding Study In Neonates

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Neonates admitted to the Neonatal Intensive Care Unit who need short procedural sedation for (semi-) elective intubation will be considered for inclusion, after informed written consent of the parents.~* Patients can be included if they are hemodynamically stable and did not receive sedative or analgesic agents during the previous 24 hours.~Exclusion Criteria:~* Known propofol intolerance

- Gender: ALL
- Minimum Age: 1 Day
- Maximum Age: 28 Days
- Healthy Volunteers: f

Study Arms:
- propofol (Type: OTHER): All patients receive propofol. Dose will be defined based on response of previous patient in the same stratum.

Based on this trial design, predict the completion outcome and termination type (if applicable).